Brainstorm Cell Therapeutics Financial Overview
Brainstorm Cell Therapeutics's market cap is currently $6.40M. The company's EPS TTM is $-0.19; its P/E ratio is -0.38; Brainstorm Cell Therapeutics is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.28. See an overview of income statement, balance sheet, and cash flow financials.
